The Pharmaceuticals in Dosage market per capita in Croatia displayed noticeable variability over the past decade. From 2013 to 2023, the market showed a slight, fluctuating trend, peaking in 2021 with a value of 592.70 USD and stabilizing around 545.25 USD in 2023. Notably, a year-on-year decline was observed from 2021 to 2023. Over the past five years, the compound annual growth rate (CAGR) averaged moderately around 0.95%, indicating a relatively stable market with slight recent contractions.
Looking ahead, important trends to monitor include potential impacts of healthcare policy changes, innovations in drug formulations, economic conditions affecting pharmaceutical affordability, and increasing demand for personalized medicine which could drive market dynamics. These factors can significantly influence future per capita expenditure in this sector.
How does Croatia rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 18 | 18 Portugal | 655.41 | 2023 | View data | ||
| 19 | 19 Slovakia | 566.89 | 2023 | View data | ||
| 20 | 20 Croatia | 545.25 | 2023 | |||
| 21 | 21 New Zealand | 520.16 | 2023 | View data | ||
| 22 | 22 Cyprus | 493.01 | 2023 | View data | ||
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
